{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:50:54Z","timestamp":1786467054107,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY381"],"award-info":[{"award-number":["2025KY381"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2026HY1286"],"award-info":[{"award-number":["2026HY1286"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011498","name":"Shaoxing Bureau of Science and Technology","doi-asserted-by":"publisher","award":["2024A14017"],"award-info":[{"award-number":["2024A14017"]}],"id":[{"id":"10.13039\/501100011498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011498","name":"Shaoxing Bureau of Science and Technology","doi-asserted-by":"publisher","award":["2023A14023"],"award-info":[{"award-number":["2023A14023"]}],"id":[{"id":"10.13039\/501100011498","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08385-7","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:15:49Z","timestamp":1781198149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dihydrotanshinone I as a novel signal transducer and activator of transcription 3 inhibitor for glioblastoma treatment"],"prefix":"10.1186","volume":"24","author":[{"given":"Kai-wen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-qian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-yan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-chen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-shan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"8385_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cac2.12627","volume":"45","author":"X Diao","year":"2025","unstructured":"Diao X, Guo C, Jin Y, Li B, Gao X, Du X, Chen Z, Jo M, Zeng Y, Ding C, et al. Cancer situation in China: an analysis based on the global epidemiological data released in 2024. Cancer Commun (Lond). 2025;45:178\u201397.","journal-title":"Cancer Commun (Lond)"},{"key":"8385_CR2","doi-asserted-by":"publisher","first-page":"102779","DOI":"10.1016\/j.canep.2025.102779","volume":"95","author":"S Mangiaterra","year":"2025","unstructured":"Mangiaterra S, Boffetta P, Seyyedsalehi MS. Occupational benzene exposure and risk of nervous system cancers: A systematic review and meta-analysis. Cancer Epidemiol. 2025;95:102779.","journal-title":"Cancer Epidemiol"},{"key":"8385_CR3","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1038\/s41467-021-24293-4","volume":"12","author":"Y Lu","year":"2021","unstructured":"Lu Y, Ng AHC, Chow FE, Everson RG, Helmink BA, Tetzlaff MT, Thakur R, Wargo JA, Cloughesy TF, Prins RM, Heath JR. Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1. Nat Commun. 2021;12:4031.","journal-title":"Nat Commun"},{"key":"8385_CR4","doi-asserted-by":"publisher","first-page":"188616","DOI":"10.1016\/j.bbcan.2021.188616","volume":"1876","author":"MS Tomar","year":"2021","unstructured":"Tomar MS, Kumar A, Srivastava C, Shrivastava A. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. Biochim Biophys Acta Rev Cancer. 2021;1876:188616.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8385_CR5","doi-asserted-by":"publisher","first-page":"eadr1481","DOI":"10.1126\/sciadv.adr1481","volume":"11","author":"JL Jimenez-Macias","year":"2025","unstructured":"Jimenez-Macias JL, Vaughn-Beaucaire P, Bharati A, Xu Z, Forrest M, Hong J, Sun M, Schmidt A, Clark J, Hawkins W, et al. Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM. Sci Adv. 2025;11:eadr1481.","journal-title":"Sci Adv"},{"key":"8385_CR6","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1038\/s41467-025-57598-9","volume":"16","author":"H Zheng","year":"2025","unstructured":"Zheng H, Zhang L, Bai X, Zhu J, Liu S, Ke Y, Lin Q, Yuan Y, Ji T. GCN5-targeted dual-modal probe across the blood-brain barrier for borders display in invasive glioblastoma. Nat Commun. 2025;16:2345.","journal-title":"Nat Commun"},{"key":"8385_CR7","doi-asserted-by":"publisher","first-page":"e15022","DOI":"10.7717\/peerj.15022","volume":"11","author":"L Wang","year":"2023","unstructured":"Wang L, Xu X, Chen D, Li C. Dihydrotanshinone I inhibits hepatocellular carcinoma cells proliferation through DNA damage and EGFR pathway. PeerJ. 2023;11:e15022.","journal-title":"PeerJ"},{"key":"8385_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13020-024-00995-x","volume":"19","author":"P Tan","year":"2024","unstructured":"Tan P, Wei X, Huang H, Wang F, Wang Z, Xie J, Wang L, Liu D, Hu Z. Application of omics technologies in studies on antitumor effects of Traditional Chinese Medicine. Chin Med. 2024;19:123.","journal-title":"Chin Med"},{"key":"8385_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.21037\/atm-23-144","volume":"11","author":"X Liu","year":"2023","unstructured":"Liu X, Yuan C, Lu X, Dong T, He G, Su D, Wang R, Jing L, Cai G, Ren J. Efficacy and influencing factors of Insect Compound Particle combined with chemotherapy for mismatch repair-related locally advanced stage III CRC who had undergone surgery and achieved R0 resection: a multicenter, double-blind, randomized, placebo-controlled clinical trial protocol. Ann Transl Med. 2023;11:127.","journal-title":"Ann Transl Med"},{"key":"8385_CR10","doi-asserted-by":"publisher","first-page":"118281","DOI":"10.1016\/j.jep.2024.118281","volume":"331","author":"J Bai","year":"2024","unstructured":"Bai J, Qin Q, Li S, Cui X, Zhong Y, Yang L, An L, Deng D, Zhao J, Zhang R, Bai S. Salvia miltiorrhiza inhibited lung cancer through aerobic glycolysis suppression. J Ethnopharmacol. 2024;331:118281.","journal-title":"J Ethnopharmacol"},{"key":"8385_CR11","doi-asserted-by":"publisher","first-page":"116635","DOI":"10.1016\/j.biopha.2024.116635","volume":"175","author":"J Yue","year":"2024","unstructured":"Yue J, Hao D, Wang Y, Guo J, Liu S, Meng L, Liu J. The multifaceted mechanisms of Dihydrotanshinone I in the treatment of tumors. Biomed Pharmacother. 2024;175:116635.","journal-title":"Biomed Pharmacother"},{"key":"8385_CR12","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.31557\/APJCP.2021.22.7.2177","volume":"22","author":"A Kashyap","year":"2021","unstructured":"Kashyap A, Umar SM, Dev JRA, Prasad CP. Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer Cells. Asian Pac J Cancer Prev. 2021;22:2177\u201384.","journal-title":"Asian Pac J Cancer Prev"},{"key":"8385_CR13","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1080\/13880209.2016.1199045","volume":"54","author":"R Cheng","year":"2016","unstructured":"Cheng R, Chen J, Wang Y, Ge Y, Huang Z, Zhang G. Dihydrotanshinone induces apoptosis of SGC7901 and MGC803 cells via activation of JNK and p38 signalling pathways. Pharm Biol. 2016;54:3019\u201325.","journal-title":"Pharm Biol"},{"key":"8385_CR14","doi-asserted-by":"publisher","first-page":"865435","DOI":"10.1155\/2011\/865435","volume":"2011","author":"MT Chuang","year":"2011","unstructured":"Chuang MT, Ho FM, Wu CC, Zhuang SY, Lin SY, Suk FM, Liang YC. 15,16-Dihydrotanshinone I, a Compound of Salvia miltiorrhiza Bunge, Induces Apoptosis through Inducing Endoplasmic Reticular Stress in Human Prostate Carcinoma Cells. Evid Based Complement Alternat Med. 2011;2011:865435.","journal-title":"Evid Based Complement Alternat Med"},{"key":"8385_CR15","doi-asserted-by":"publisher","first-page":"157023","DOI":"10.1016\/j.phymed.2025.157023","volume":"145","author":"B Han","year":"2025","unstructured":"Han B, Sun C, Yang R, Li X, Kang J, Cai J, Zhou S, Wang G, Wang J, Zhang J, et al. Dihydrotanshinone I inhibits ovarian tumor growth by suppressing ITGB1\/FAK-mediated extracellular matrix signaling. Phytomedicine. 2025;145:157023.","journal-title":"Phytomedicine"},{"key":"8385_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.freeradbiomed.2022.01.015","volume":"180","author":"C Sun","year":"2022","unstructured":"Sun C, Han B, Zhai Y, Zhao H, Li X, Qian J, Hao X, Liu Q, Shen J, Kai G. Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation. Free Radic Biol Med. 2022;180:220\u201335.","journal-title":"Free Radic Biol Med"},{"key":"8385_CR17","doi-asserted-by":"crossref","unstructured":"Allegri L, Domenis R, Navarra M, Celano M, Russo D, Capriglione F, Damante G, Baldan F. Dihydrotanshinone exerts antitumor effects and improves the effects of cisplatin in anaplastic thyroid cancer cells. Oncol Rep. 2021;46.","DOI":"10.3892\/or.2021.8155"},{"key":"8385_CR18","doi-asserted-by":"crossref","unstructured":"Wang M, Xiang Y, Wang R, Zhang L, Zhang H, Chen H, Luan X, Chen L. Dihydrotanshinone I inhibits the proliferation and growth of oxaliplatin-resistant human HCT116 colorectal cancer cells. Molecules. 2022;27.","DOI":"10.3390\/molecules27227774"},{"key":"8385_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3892\/ol.2020.11980","volume":"20","author":"S Tan","year":"2020","unstructured":"Tan S, Hou X, Mei L. Dihydrotanshinone I inhibits human glioma cell proliferation via the activation of ferroptosis. Oncol Lett. 2020;20:122.","journal-title":"Oncol Lett"},{"key":"8385_CR20","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1080\/01635581.2021.1931361","volume":"74","author":"JC Chen","year":"2022","unstructured":"Chen JC, Hwang JH. Caffeine Inhibits Growth of Temozolomide-Treated Glioma via Increasing Autophagy and Apoptosis but Not via Modulating Hypoxia, Angiogenesis, or Endoplasmic Reticulum Stress in Rats. Nutr Cancer. 2022;74:1090\u20136.","journal-title":"Nutr Cancer"},{"key":"8385_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jconrel.2022.05.057","volume":"348","author":"S Han","year":"2022","unstructured":"Han S, Bi S, Guo T, Sun D, Zou Y, Wang L, Song L, Chu D, Liao A, Song X, et al. Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer. J Control Release. 2022;348:250\u201363.","journal-title":"J Control Release"},{"key":"8385_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1172\/JCI59334","volume":"122","author":"S Agnihotri","year":"2012","unstructured":"Agnihotri S, Gajadhar AS, Ternamian C, Gorlia T, Diefes KL, Mischel PS, Kelly J, McGown G, Thorncroft M, Carlson BL, et al. Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients. J Clin Invest. 2012;122:253\u201366.","journal-title":"J Clin Invest"},{"key":"8385_CR23","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/2159-8290.CD-21-1434","volume":"12","author":"G Crisafulli","year":"2022","unstructured":"Crisafulli G, Sartore-Bianchi A, Lazzari L, Pietrantonio F, Amatu A, Macagno M, Barault L, Cassingena A, Bartolini A, Luraghi P, et al. Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients. Cancer Discov. 2022;12:1656\u201375.","journal-title":"Cancer Discov"},{"key":"8385_CR24","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.cell.2021.03.009","volume":"184","author":"SC Dentro","year":"2021","unstructured":"Dentro SC, Leshchiner I, Haase K, Tarabichi M, Wintersinger J, Deshwar AG, Yu K, Rubanova Y, Macintyre G, Demeulemeester J, et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell. 2021;184:2239\u2013e22542239.","journal-title":"Cell"},{"key":"8385_CR25","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1093\/bioinformatics\/btt540","volume":"29","author":"D Gfeller","year":"2013","unstructured":"Gfeller D, Michielin O, Zoete V. Shaping the interaction landscape of bioactive molecules. Bioinformatics. 2013;29:3073\u20139.","journal-title":"Bioinformatics"},{"key":"8385_CR26","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47:W357\u201364.","journal-title":"Nucleic Acids Res"},{"key":"8385_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.","journal-title":"J Cheminform"},{"key":"8385_CR28","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","volume":"44","author":"D Szklarczyk","year":"2016","unstructured":"Szklarczyk D, Santos A, von Mering C, Jensen LJ, Bork P, Kuhn M. STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2016;44:D380\u2013384.","journal-title":"Nucleic Acids Res"},{"key":"8385_CR29","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1021\/acs.jcim.5b00690","volume":"56","author":"X Wang","year":"2016","unstructured":"Wang X, Pan C, Gong J, Liu X, Li H. Enhancing the Enrichment of Pharmacophore-Based Target Prediction for the Polypharmacological Profiles of Drugs. J Chem Inf Model. 2016;56:1175\u201383.","journal-title":"J Chem Inf Model"},{"key":"8385_CR30","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X, Lai L, Pei J, Li H. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45:W356\u201360.","journal-title":"Nucleic Acids Res"},{"key":"8385_CR31","doi-asserted-by":"crossref","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y, et al. The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1 30 31\u201331 30 33.","DOI":"10.1002\/cpbi.5"},{"key":"8385_CR32","doi-asserted-by":"publisher","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","volume":"45","author":"N Rappaport","year":"2017","unstructured":"Rappaport N, Twik M, Plaschkes I, Nudel R, Iny Stein T, Levitt J, Gershoni M, Morrey CP, Safran M, Lancet D. MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Res. 2017;45:D877\u201387.","journal-title":"Nucleic Acids Res"},{"key":"8385_CR33","doi-asserted-by":"publisher","first-page":"D789","DOI":"10.1093\/nar\/gku1205","volume":"43","author":"JS Amberger","year":"2015","unstructured":"Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: Online Mendelian Inheritance in Man (OMIM(R)), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015;43:D789\u2013798.","journal-title":"Nucleic Acids Res"},{"key":"8385_CR34","doi-asserted-by":"publisher","first-page":"D1038","DOI":"10.1093\/nar\/gky1151","volume":"47","author":"JS Amberger","year":"2019","unstructured":"Amberger JS, Bocchini CA, Scott AF, Hamosh A. OMIM.org: leveraging knowledge across phenotype-gene relationships. Nucleic Acids Res. 2019;47:D1038\u201343.","journal-title":"Nucleic Acids Res"},{"key":"8385_CR35","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Y, Zhao D, Yu X, Shen X, Zhou Y, Wang S, Qiu Y, Chen Y, Zhu F. TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Res. 2024;52:D1465\u201377.","journal-title":"Nucleic Acids Res"},{"key":"8385_CR36","doi-asserted-by":"publisher","first-page":"180158","DOI":"10.1038\/sdata.2018.158","volume":"5","author":"Y Gusev","year":"2018","unstructured":"Gusev Y, Bhuvaneshwar K, Song L, Zenklusen JC, Fine H, Madhavan S. The REMBRANDT study, a large collection of genomic data from brain cancer patients. Sci Data. 2018;5:180158.","journal-title":"Sci Data"},{"key":"8385_CR37","doi-asserted-by":"publisher","first-page":"D1110","DOI":"10.1093\/nar\/gky1021","volume":"47","author":"Y Wu","year":"2019","unstructured":"Wu Y, Zhang F, Yang K, Fang S, Bu D, Li H, Sun L, Hu H, Gao K, Wang W, et al. SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping. Nucleic Acids Res. 2019;47:D1110\u20137.","journal-title":"Nucleic Acids Res"},{"key":"8385_CR38","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u201346.","journal-title":"Nucleic Acids Res"},{"key":"8385_CR39","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.","journal-title":"Nat Commun"},{"key":"8385_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/978-1-0716-1920-9_22","volume":"2418","author":"MHH Withanage","year":"2022","unstructured":"Withanage MHH, Liang H, Zeng E. RNA-Seq Experiment and Data Analysis. Methods Mol Biol. 2022;2418:405\u201324.","journal-title":"Methods Mol Biol"},{"key":"8385_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-0716-3918-4_18","volume":"2822","author":"J Li","year":"2024","unstructured":"Li J, Varghese RS, Ressom HW. RNA-Seq Data Analysis. Methods Mol Biol. 2024;2822:263\u201390.","journal-title":"Methods Mol Biol"},{"key":"8385_CR42","doi-asserted-by":"publisher","first-page":"101286","DOI":"10.1016\/j.gendis.2024.101286","volume":"12","author":"Q Sun","year":"2025","unstructured":"Sun Q, Lei X, Yang X. The crosstalk between non-coding RNAs and oxidative stress in cancer progression. Genes Dis. 2025;12:101286.","journal-title":"Genes Dis"},{"key":"8385_CR43","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"8385_CR44","first-page":"541","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Qu S, Zuo J, Long H, Cao F, Jiang F. Progress on the functions and mechanisms of natural products in anti-glioma therapy. Chin J Nat Med. 2025;23:541\u201359.","journal-title":"Chin J Nat Med"},{"key":"8385_CR45","doi-asserted-by":"publisher","first-page":"151959","DOI":"10.1016\/j.bbrc.2025.151959","volume":"768","author":"Z Xing","year":"2025","unstructured":"Xing Z, Wei X, Fan Q, Zhao D, He J, Cheng J. Cryptotanshinone promotes ferroptosis in glioblastoma via KEAP1\/NRF2\/HMOX1 signaling pathway. Biochem Biophys Res Commun. 2025;768:151959.","journal-title":"Biochem Biophys Res Commun"},{"key":"8385_CR46","doi-asserted-by":"publisher","first-page":"106740","DOI":"10.1016\/j.oraloncology.2024.106740","volume":"151","author":"Y Hua","year":"2024","unstructured":"Hua Y, Ma P, Li C, Gao N, Ding Z. Association between COVID 19 exposure and expression of malignant pathological features in oral squamous cell carcinoma: A retrospective cohort study. Oral Oncol. 2024;151:106740.","journal-title":"Oral Oncol"},{"key":"8385_CR47","doi-asserted-by":"publisher","first-page":"e2767","DOI":"10.1038\/cddis.2017.174","volume":"8","author":"L Lu","year":"2017","unstructured":"Lu L, Zhang S, Li C, Zhou C, Li D, Liu P, Huang M, Shen X. Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation. Cell Death Dis. 2017;8:e2767.","journal-title":"Cell Death Dis"},{"key":"8385_CR48","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.biopha.2018.06.047","volume":"105","author":"L Di Cesare Mannelli","year":"2018","unstructured":"Di Cesare Mannelli L, Piccolo M, Maione F, Ferraro MG, Irace C, De Feo V, Ghelardini C, Mascolo N. Tanshinones from Salvia miltiorrhiza Bunge revert chemotherapy-induced neuropathic pain and reduce glioblastoma cells malignancy. Biomed Pharmacother. 2018;105:1042\u20139.","journal-title":"Biomed Pharmacother"},{"key":"8385_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11060-006-9242-x","volume":"82","author":"J Wang","year":"2007","unstructured":"Wang J, Wang X, Jiang S, Yuan S, Lin P, Zhang J, Lu Y, Wang Q, Xiong Z, Wu Y, et al. Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells. J Neurooncol. 2007;82:11\u201321.","journal-title":"J Neurooncol"},{"key":"8385_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neulet.2009.12.069","volume":"470","author":"C Tang","year":"2010","unstructured":"Tang C, Xue HL, Huang HB, Wang XG. Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells. Neurosci Lett. 2010;470:126\u20139.","journal-title":"Neurosci Lett"},{"key":"8385_CR51","doi-asserted-by":"publisher","first-page":"107980","DOI":"10.1016\/j.neuropharm.2020.107980","volume":"167","author":"C Zhang","year":"2020","unstructured":"Zhang C, Pan Y, Cai R, Guo S, Zhang X, Xue Y, Wang J, Huang J, Wang J, Gu Y, Zhang Z. Salvianolic acid A increases the accumulation of doxorubicin in brain tumors through Caveolae endocytosis. Neuropharmacology. 2020;167:107980.","journal-title":"Neuropharmacology"},{"key":"8385_CR52","doi-asserted-by":"publisher","first-page":"11646","DOI":"10.1080\/21655979.2022.2070963","volume":"13","author":"T Ye","year":"2022","unstructured":"Ye T, Chen R, Zhou Y, Zhang J, Zhang Z, Wei H, Xu Y, Wang Y, Zhang Y. Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) \/ protein kinase B (Akt) pathway. Bioengineered. 2022;13:11646\u201355.","journal-title":"Bioengineered"},{"key":"8385_CR53","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.biopha.2018.08.113","volume":"107","author":"W Chen","year":"2018","unstructured":"Chen W, Wang N, Li RC, Xu GF, Bao G, Jiang HT, Wang MD. Salvianolic acid B renders glioma cells more sensitive to radiation via Fis-1-mediated mitochondrial dysfunction. Biomed Pharmacother. 2018;107:1230\u20136.","journal-title":"Biomed Pharmacother"},{"key":"8385_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.17305\/bjbms.2017.1800","volume":"17","author":"Y Cao","year":"2017","unstructured":"Cao Y, Huang B, Gao C. Salvia miltiorrhiza extract dihydrotanshinone induces apoptosis and inhibits proliferation of glioma cells. Bosn J Basic Med Sci. 2017;17:235\u201340.","journal-title":"Bosn J Basic Med Sci"},{"key":"8385_CR55","first-page":"6025","volume":"37","author":"V Kumar","year":"2017","unstructured":"Kumar V, Radin D, Leonardi D. Probing the Oncolytic and Chemosensitizing Effects of Dihydrotanshinone in an In Vitro Glioblastoma Model. Anticancer Res. 2017;37:6025\u201330.","journal-title":"Anticancer Res"},{"key":"8385_CR56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.it.2006.11.007","volume":"28","author":"I Bechmann","year":"2007","unstructured":"Bechmann I, Galea I, Perry VH. What is the blood-brain barrier (not)? Trends Immunol. 2007;28:5\u201311.","journal-title":"Trends Immunol"},{"key":"8385_CR57","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhou F, Ali H, Lathia JD, Chen P. Immunotherapy for glioblastoma: current state, challenges, and future perspectives. Cell Mol Immunol. 2024;21:1354\u201375.","journal-title":"Cell Mol Immunol"},{"key":"8385_CR58","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41417-025-00906-8","volume":"32","author":"F Martins","year":"2025","unstructured":"Martins F, Arada R, Barros H, Matos P, Ramalho J, Cena V, Bonifacio VDB, Goncalves LG, Serpa J. Lactate-coated polyurea-siRNA dendriplex: a gene therapy-directed and metabolism-based strategy to impair glioblastoma (GBM). Cancer Gene Ther. 2025;32:690\u2013705.","journal-title":"Cancer Gene Ther"},{"key":"8385_CR59","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41586-025-08634-7","volume":"641","author":"Y Sun","year":"2025","unstructured":"Sun Y, Wang X, Zhang DY, Zhang Z, Bhattarai JP, Wang Y, Park KH, Dong W, Hung YF, Yang Q, et al. Brain-wide neuronal circuit connectome of human glioblastoma. Nature. 2025;641:222\u201331.","journal-title":"Nature"},{"key":"8385_CR60","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41467-021-20959-1","volume":"12","author":"Y Ma","year":"2021","unstructured":"Ma Y, Cui G, Chen T, Ma X, Wang R, Jin B, Yang J, Kang L, Tang J, Lai C, et al. Expansion within the CYP71D subfamily drives the heterocyclization of tanshinones synthesis in Salvia miltiorrhiza. Nat Commun. 2021;12:685.","journal-title":"Nat Commun"},{"key":"8385_CR61","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.redox.2013.10.004","volume":"1","author":"S Tao","year":"2013","unstructured":"Tao S, Justiniano R, Zhang DD, Wondrak GT. The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV. Redox Biol. 2013;1:532\u201341.","journal-title":"Redox Biol"},{"key":"8385_CR62","doi-asserted-by":"publisher","first-page":"13621","DOI":"10.3390\/ijms131013621","volume":"13","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Jiang P, Ye M, Kim SH, Jiang C, Lu J. Tanshinones: sources, pharmacokinetics and anti-cancer activities. Int J Mol Sci. 2012;13:13621\u201366.","journal-title":"Int J Mol Sci"},{"key":"8385_CR63","doi-asserted-by":"crossref","unstructured":"Luo P, Huang Y, Hang X, Tong Q, Zeng L, Jia J, Zhang G, Bi H. Dihydrotanshinone I is effective against drug-resistant helicobacter pylori in vitro and in vivo. Antimicrob Agents Chemother. 2021;65.","DOI":"10.1128\/AAC.01921-20"},{"key":"8385_CR64","doi-asserted-by":"publisher","first-page":"155767","DOI":"10.1016\/j.phymed.2024.155767","volume":"130","author":"Y Nie","year":"2024","unstructured":"Nie Y, Yan J, Huang X, Jiang T, Zhang S, Zhang G. Dihydrotanshinone I targets ESR1 to induce DNA double-strand breaks and proliferation inhibition in hepatocellular carcinoma. Phytomedicine. 2024;130:155767.","journal-title":"Phytomedicine"},{"key":"8385_CR65","doi-asserted-by":"publisher","first-page":"e77935","DOI":"10.1371\/journal.pone.0077935","volume":"8","author":"JL Voorhees","year":"2013","unstructured":"Voorhees JL, Powell ND, Moldovan L, Mo X, Eubank TD, Marsh CB. Chronic restraint stress upregulates erythropoiesis through glucocorticoid stimulation. PLoS ONE. 2013;8:e77935.","journal-title":"PLoS ONE"},{"key":"8385_CR66","doi-asserted-by":"publisher","first-page":"1482050","DOI":"10.3389\/fonc.2025.1482050","volume":"15","author":"X Ma","year":"2025","unstructured":"Ma X, Sun C, Ding X, Zhang Y, Deng T, Wang Y, Yang H, Ding R, Li H, Wang D, Zheng M. Advances in the treatment of glioma-related signaling pathways and mechanisms by metformin. Front Oncol. 2025;15:1482050.","journal-title":"Front Oncol"},{"key":"8385_CR67","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s12672-025-03279-4","volume":"16","author":"WC Hsieh","year":"2025","unstructured":"Hsieh WC, Lin CY, Wu HC, Lo HW, Ko CY, Chuang JY, Hsu TI, Tseng TH, Huang TW, Wang SM. Calanquinone A suppresses glioma progression via STAT3-mediated regulation of c-Myc and MMP9. Discov Oncol. 2025;16:1463.","journal-title":"Discov Oncol"},{"key":"8385_CR68","doi-asserted-by":"publisher","first-page":"893","DOI":"10.4251\/wjgo.v13.i8.893","volume":"13","author":"MM Qi","year":"2021","unstructured":"Qi MM, He PZ, Zhang L, Dong WG. STAT3-mediated activation of mitochondrial pathway contributes to antitumor effect of dihydrotanshinone I in esophageal squamous cell carcinoma cells. World J Gastrointest Oncol. 2021;13:893\u2013914.","journal-title":"World J Gastrointest Oncol"},{"key":"8385_CR69","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3892\/ol.2025.14881","volume":"29","author":"H Cheng","year":"2025","unstructured":"Cheng H, Chen L, Huang C. Advances of signal transducer and activator of transcription 3 inhibitors in acute myeloid leukemia (Review). Oncol Lett. 2025;29:134.","journal-title":"Oncol Lett"},{"key":"8385_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10522-025-10193-3","volume":"26","author":"M Shi","year":"2025","unstructured":"Shi M, Li H, Liang R, Lin H, Tang Q. The transcription factor STAT3 and aging: an intermediate medium. Biogerontology. 2025;26:55.","journal-title":"Biogerontology"},{"key":"8385_CR71","doi-asserted-by":"publisher","first-page":"1429018","DOI":"10.3389\/fonc.2025.1429018","volume":"15","author":"X Luo","year":"2025","unstructured":"Luo X, Duan Y, He J, Huang C, Liu J, Liu Y, Xu M, Dai Q, Yang Z. Dihydrotanshinone I enhanced BRAF mutant melanoma treatment efficacy by inhibiting the STAT3\/SOX2 signaling pathway. Front Oncol. 2025;15:1429018.","journal-title":"Front Oncol"},{"key":"8385_CR72","doi-asserted-by":"publisher","first-page":"654986","DOI":"10.3389\/fphar.2021.654986","volume":"12","author":"X Hu","year":"2021","unstructured":"Hu X, Jiao F, Zhang L, Jiang Y. Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2\/STAT3 Pathway. Front Pharmacol. 2021;12:654986.","journal-title":"Front Pharmacol"},{"key":"8385_CR73","doi-asserted-by":"publisher","first-page":"8833885","DOI":"10.1155\/2020\/8833885","volume":"2020","author":"B Liang","year":"2020","unstructured":"Liang B, Li SY, Gong HZ, Wang LX, Lu J, Zhao YX, Gu N. Clinicopathological and Prognostic Roles of STAT3 and Its Phosphorylation in Glioma. Dis Markers. 2020;2020:8833885.","journal-title":"Dis Markers"},{"key":"8385_CR74","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11010-013-1709-4","volume":"381","author":"Z Xiong","year":"2013","unstructured":"Xiong Z, Wang Y, Gong W, Zhou Z, Lu G. Expression of Hsp27 correlated with rat detrusor contraction after acute urinary retention. Mol Cell Biochem. 2013;381:257\u201365.","journal-title":"Mol Cell Biochem"},{"key":"8385_CR75","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11010-013-1711-x","volume":"381","author":"L Lu","year":"2013","unstructured":"Lu L, Li C, Li D, Wang Y, Zhou C, Shao W, Peng J, You Y, Zhang X, Shen X. Cryptotanshinone inhibits human glioma cell proliferation by suppressing STAT3 signaling. Mol Cell Biochem. 2013;381:273\u201382.","journal-title":"Mol Cell Biochem"},{"key":"8385_CR76","doi-asserted-by":"publisher","first-page":"858","DOI":"10.18632\/oncotarget.28516","volume":"14","author":"JB Anderson","year":"2023","unstructured":"Anderson JB, Bouchal SM, Zhang L, Daniels DJ. STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma. Oncotarget. 2023;14:858\u20139.","journal-title":"Oncotarget"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08385-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08385-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08385-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:02:15Z","timestamp":1786464135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08385-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8385"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08385-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures involving human participants were conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Shaoxing People\u2019s Hospital (Approval No. 2025-90-Y-01). Written informed consent was obtained from all participants, and patient privacy was strictly protected in compliance with applicable laws and regulations. Animal experiments were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals of the U.S. National Institutes of Health and were approved by the Animal Ethics Committee of Shaoxing People\u2019s Hospital (Approval No. 2025Z025). All experimental protocols were designed to minimize animal suffering and strictly followed the ARRIVE guidelines for preclinical research.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have any competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1029"}}